Skip to main content
Springer Nature Link
Log in

A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

A new model for the study of spontaneous bone metastasis has been developed which allows for the quantification of metastatic tumor burden and cancer cell growth rate, and which describes the progressive changes in bone morphology. Walker 256 (W256) cells or vehicle were injected into the left upper thigh muscle of male Fischer rats, which were killed 7, 10 or 14 days later. By day 7, metastases had appeared in the distal femur, in the glomeruli of the kidney, and diffusely throughout the liver and lungs. The extent of tumor burden in these organs increased over time. In the femur, 14 days of tumor burden was associated with a 53 ± 10% decrease in trabecular bone content, a 61 ± 15% increase in osteoclast surface, and a 95 ± 10% decrease in osteoblast surface, as compared with non-tumor-bearing controls. By autoradiography, metastatic tumor cells in all organs were determined to have greater growth rates than did cells in the primary tumor. However, within the femur, W256 cells located adjacent to trabecular bone surfaces had a 33 ± 7% greater growth rate than did W256 cells located >50 µm from bone surfaces (P < 0.05), suggesting a mitogenic effect of bone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nicolson GL, 1988, Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer and Metastasis Reviews, 7, 143–188.

    Google Scholar 

  2. Percival RC, Yates AJP, Gray RES, Galloway J, Rogers K, Neal FE and Kanis JA, 1985, Mechanisms of malignant hypercalcemia in carcinoma of the breast. British Medical Journal, 291, 776–777.

    Google Scholar 

  3. Plesnicar S, 1985, The course of metastatic disease originating from carcinoma of the prostate. Clinical and Experimental Metastasis, 3, 103–110.

    Google Scholar 

  4. Elte JWF, Bijvoet OLM, Cleton FJ, Van Oosterom AT and Sleeboom HP, 1986, Osteolytic bone metastases in breast carcinoma: pathogenesis, morbidity, and bisphosphonate treatment. European Journal of Cancer and Clinical Oncology, 22, 493–500.

    Google Scholar 

  5. Mundy GR, Demartino S and Rowe DW, 1981, Collagen and collagen-derived fragments are chemotactic for tumor cells. Journal of Clinical Investigation, 68, 1102–1105.

    Google Scholar 

  6. Millar-Book W, Orr FW and Singh G, 1990, In vitro effects of bone and platelet-derived transforming growth factor-β on the growth of Walker 256 carcinosarcoma cells. Clinical and Experimental Metastasis, 8, 503–510.

    Google Scholar 

  7. Orr FW, Millar-Book W and Singh G, 1990, Chemotactic activity of bone and platelet-derived transforming growth factor beta for bone-metastasizing rat Walker 256 carcinosarcoma cells. Invasion and Metastasis, 10, 241–252.

    Google Scholar 

  8. Simpkins H, Lehman JM, Mazurkiewicz JE and Davis BH, 1991, A morphological and phenotypical analysis of Walker 256 cells. Cancer Research, 51, 1334–1338.

    Google Scholar 

  9. Minne H, Ratte F, Bellwinkel S and Ziegler R, 1975, The hypercalcemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinologica, 78, 613–624.

    Google Scholar 

  10. Jung A, Bornand, J, Mermillod B, Edouard C and Meunier PJ, 1984, Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Research, 44, 3007–3011.

    Google Scholar 

  11. Orr FW, Varani J, Gondek MD, Ward PA and Mundy GR, 1979, Chemotactic responses of tumor cells to products of resorbing bone. Science, 203, 176–179.

    Google Scholar 

  12. Orr FW, Varani J, Gondek MD, Ward PA and Mundy GR, 1980, Partial characterization of a bone-derived chemotactic factor for tumor cells. American Journal of Pathology, 99, 43–52.

    Google Scholar 

  13. Magro C, Orr FW, Manishen WJ, Sivananthan K and Mokashi S, 1985, Adhesion, chemotaxis, and aggregation of Walker carcinosarcoma cells in response to products of resorbing bone. Journal of the National Cancer Institute, 74, 829–834.

    Google Scholar 

  14. Manishen WJ, Sivananthan K and Orr FW, 1986, Resorbing bone stimulates tumor cell growth. American Journal of Pathology, 123, 39–45.

    Google Scholar 

  15. Guaitani A, Polentarutti N, Filippeschi S, Marmonti L, Corti F, Italia C, Coccioli G, Donell MG, Mantovani A and Garattini S, 1985, Effects of disodium etidronate in murine tumor models. European Journal of Cancer and Clinical Oncology, 20, 685–693.

    Google Scholar 

  16. Bassani D, Sabatini M, Scanziani E, De Francesco L, Coccioli G, Guaitani A and Bartosek I, 1990, Bone invasion by Walker 256 carcinoma, line A in young and adult rats: effects of etidronate. Oncology, 47, 160–165.

    Google Scholar 

  17. Krempien B, Wingen F, Eichmann T, Muller M and Schmahl D, 1988, Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256. Oncology, 45, 41–46.

    Google Scholar 

  18. Powles TJ, Clark SA, Easty DM, Easty GC and Neville AM, 1973, The inhibition by aspirin and indomethacin of osteolytic tumour deposits and hypercalcemia in rats with Walker tumor, and its possible application to human breast cancer. British Journal of Cancer, 28, 316–321.

    Google Scholar 

  19. Schmidt-Gayk H, Lohrke H, Fishkal A, Goerttler K and Hofmann F, 1979, Urinary cyclic AMP and bone histology in Walker carcinosarcoma: evidence of parathyroid hormone-like activity. European Journal of Cancer, 15, 1211–1218.

    Google Scholar 

  20. Krempien B, 1984, The Walker carcinosarcoma 256 as an experimental model of bone metastases: influence of local and metabolic factors on incidence and pattern of metastases. Calcified Tissue International, 36, S26.

    Google Scholar 

  21. Rayner DC, Orr FW and Shiu RPC, 1985, Binding of formyl peptides of Walker 256 carcinosarcoma cells and the chemotactic response of these cells. Cancer Research, 45, 2288–2293.

    Google Scholar 

  22. Schenk RK. Principles of bone morphometry. In: Jaworski ZFG, ed. Proceedings of the First Workshop on Bone Morphometry. Ottawa: University of Ottawa Press, 1976.

    Google Scholar 

  23. Revell PA. Quantitative methods in bone biopsy examination. In: Revell PA, ed. Pathology of Bone. New York, NY: Springer Verlag, 1986.

    Google Scholar 

  24. Nemoto R, 1991, New bone formation and cancer implants: relationship to tumor proliferative activity. British Journal of Cancer, 63, 348–350.

    Google Scholar 

  25. Weiss L, Haydock K, Pickren JW and Lane WW, 1980, Organ vascularity and metastatic frequency. American Journal of Pathology, 101, 101–114.

    Google Scholar 

  26. Turpeenniemi-Hujanen T, Thorgeirsson UP, Hart IR, Grant SS and Liotta LA, 1985, Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. Journal of the National Cancer Institute, 75, 99–103.

    Google Scholar 

  27. Perrotti D, Cimino L, Falcioni R, Tibursi G, Gentileschi MP and Sacchi A, 1990, Metastatic phenotype: growth factor dependence and integrin expression. Anticancer Research, 10, 1587–1598.

    Google Scholar 

  28. Nicolson GL and Dulski KM, 1986, Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. International Journal of Cancer, 38, 289–294.

    Google Scholar 

  29. Naito S, Giavazzi R and Fidler IJ, 1987, Correlation between the in vitro interaction of tumor cells with an organ environment and metastatic behaviour in vivo. Invasion and Metastasis, 7, 16–29.

    Google Scholar 

  30. Sargent NSE, Oestreicher M, Haidvogl H, Madnick HM and Burger MM, 1988, Growth regulation of cancer metastases by their host organ. Proceedings of the National Academy of Sciences, U.S.A., 85, 7251–7255.

    Google Scholar 

  31. Gleave M, Hsieh JT, Gao C, Von Eschenbach AC and Chung LWK, 1991, Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Research, 51, 3753–3761.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Oncology Research Group, McMaster University, and Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada

    Paul J. Kostenuik, Gurmit Singh, Kaye L. Suyama & F. William Orr

Authors
  1. Paul J. Kostenuik
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Gurmit Singh
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Kaye L. Suyama
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. F. William Orr
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kostenuik, P.J., Singh, G., Suyama, K.L. et al. A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metast 10, 403–410 (1992). https://doi.org/10.1007/BF00133469

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00133469

Keywords